Skip to main content

Advertisement

Table 6 Cardiovascular risk factors at the end of the study

From: Effectiveness of multidisciplinary intervention on blood pressure control in primary health care: a randomized clinical trial

Variable Group
Multidisciplinary Program Personalized Care p-value
n = 113 n = 114
FBG, mg/dL
 Diabetic 137 ± 52 (32) 135 ± 36 (33) 0.905a
 Nondiabetic 92 ± 16 (68) 93 ± 15 (67) 0.712a
HbA1c, % 6.6 ± 2 (32) 6.4 ± 1 (33) 0.634a
Total cholesterol, mg/dL 191 ± 47 (107) 198 ± 47 (104) 0.263a
HDL, mg/dL 45 ± 12 (107) 45 ± 12 (104) 0.916a
LDL, mg/dL 113 ± 41 (96) 119 ± 41 (98) 0.297a
Triglyceride, mg/dL 143 (113 – 190) (107) 143 (112 – 213) (104) 0.769b
Nondiabetic, 10 years FRS, n%
 Low 47 (63) 39 (55) 0.528c
 Medium 19 (25) 24 (34)
 High 9 (12) 8 (11)
 Mean FRS 5 (2–14) 6 (3–14) 0.647b
Diabetic, UKPDS, risk 10 year, %
 CHD 12 (8 – 17) (32) 11 (6 – 19) 0.572b
 Fatal CHD 7 (4–10) (32) 6 (3 – 13) 0.682b
 Stroke 7 (5 – 12) (32) 5.5 (3 – 12) 0.993b
 Fatal Stroke 1 (1 – 2) (32) 1 (1 – 2) 0.992b
  1. FBG Fasting blood glucose, HbA1c Glycated hemoglobin, HDL High-density lipoprotein, LDL Low-density lipoprotein cholesterol, FRS Framingham risk score, CVD Cardiovascular disease. Values expressed n (%), mean and standard deviation (SD) or median and interquartile range (IQR)
  2. aStudent’s t-test
  3. bMann-Whitney U test
  4. cPerson chi-square test